Advertisement
Screener

IRADIMED CORPORATION (IRMD) Income (Loss) from Continuing Operations before Income Taxes, Domestic

3.1 / 5 stars · 74/120 Roast Me

IRADIMED CORPORATION Income (Loss) from Continuing Operations before Income Taxes, Domestic

IRADIMED CORPORATION (IRMD) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $28.36 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.

Financial Statements › Income Statement › Pre-tax Income

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-06

  • IRADIMED CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $28.36M, a 17.01% increase from fiscal 2024.
  • IRADIMED CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $24.24M.
Period endIncome (Loss) from Continuing Operations before Income Taxes, Domestic 12 month
2025-12-31$28.36M
10-K · filed 2026-03-06
2024-12-31$24.24M
10-K · filed 2026-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ARTIVION, INC. (AORT)United States$1.123B-345.09
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02